164 related articles for article (PubMed ID: 32437694)
1. Molecular and cellular basis of the anticancer activity of the prenylated flavonoid icaritin in hepatocellular carcinoma.
Bailly C
Chem Biol Interact; 2020 Jul; 325():109124. PubMed ID: 32437694
[TBL] [Abstract][Full Text] [Related]
2. New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives.
Reyes-Hernández OD; Figueroa-González G; Quintas-Granados LI; Hernández-Parra H; Peña-Corona SI; Cortés H; Kipchakbayeva A; Mukazhanova Z; Habtemariam S; Leyva-Gómez G; Büsselberg D; Sharifi-Rad J
Drug Dev Res; 2024 Apr; 85(2):e22175. PubMed ID: 38567708
[TBL] [Abstract][Full Text] [Related]
3. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
[TBL] [Abstract][Full Text] [Related]
4. Kurarinol induces hepatocellular carcinoma cell apoptosis through suppressing cellular signal transducer and activator of transcription 3 signaling.
Shu G; Yang J; Zhao W; Xu C; Hong Z; Mei Z; Yang X
Toxicol Appl Pharmacol; 2014 Dec; 281(2):157-65. PubMed ID: 24997323
[TBL] [Abstract][Full Text] [Related]
5. Induction of ROS and DNA damage-dependent senescence by icaritin contributes to its antitumor activity in hepatocellular carcinoma cells.
Wang S; Wang Q; Wang H; Qin C; Cui X; Li L; Liu Y; Chang H
Pharm Biol; 2019 Dec; 57(1):424-431. PubMed ID: 31407933
[No Abstract] [Full Text] [Related]
6. Identification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells.
Lu PH; Chen MB; Liu YY; Wu MH; Li WT; Wei MX; Liu CY; Qin SK
Oncotarget; 2017 Apr; 8(14):22800-22810. PubMed ID: 28206952
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Structure-Activity Analysis of Icaritin Derivatives as Potential Tumor Growth Inhibitors of Hepatocellular Carcinoma Cells.
Li J; Shen S; Liu Z; Zhao H; Liu S; Liu Q; Yao GD; Song SJ
J Nat Prod; 2023 Feb; 86(2):290-306. PubMed ID: 36745506
[TBL] [Abstract][Full Text] [Related]
8. Chemical composition of total flavonoids from Polygonum amplexicaule and their pro-apoptotic effect on hepatocellular carcinoma cells: Potential roles of suppressing STAT3 signaling.
Xiang M; Su H; Hong Z; Yang T; Shu G
Food Chem Toxicol; 2015 Jun; 80():62-71. PubMed ID: 25754378
[TBL] [Abstract][Full Text] [Related]
9. Anticancer agent icaritin induces apoptosis through caspase-dependent pathways in human hepatocellular carcinoma cells.
Sun L; Peng Q; Qu L; Gong L; Si J
Mol Med Rep; 2015 Apr; 11(4):3094-100. PubMed ID: 25434584
[TBL] [Abstract][Full Text] [Related]
10. First-in-class immune-modulating small molecule Icaritin in advanced hepatocellular carcinoma: preliminary results of safety, durable survival and immune biomarkers.
Fan Y; Li S; Ding X; Yue J; Jiang J; Zhao H; Hao R; Qiu W; Liu K; Li Y; Wang S; Zheng L; Ye B; Meng K; Xu B
BMC Cancer; 2019 Mar; 19(1):279. PubMed ID: 30922248
[TBL] [Abstract][Full Text] [Related]
11. Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor.
He J; Wang Y; Duan F; Jiang H; Chen MF; Tang SY
Planta Med; 2010 Nov; 76(16):1834-9. PubMed ID: 20560114
[TBL] [Abstract][Full Text] [Related]
12. Icaritin inhibits PD-L1 expression by Targeting Protein IκB Kinase α.
Mo D; Zhu H; Wang J; Hao H; Guo Y; Wang J; Han X; Zou L; Li Z; Yao H; Zhu J; Zhou J; Peng Y; Li J; Meng K
Eur J Immunol; 2021 Apr; 51(4):978-988. PubMed ID: 33354776
[TBL] [Abstract][Full Text] [Related]
13. Chemical composition of total flavonoids from Salvia chinensia Benth and their pro-apoptotic effect on hepatocellular carcinoma cells: potential roles of suppressing cellular NF-κB signaling.
Xiang M; Su H; Hu Y; Hu Y; Yang T; Shu G
Food Chem Toxicol; 2013 Dec; 62():420-6. PubMed ID: 24036141
[TBL] [Abstract][Full Text] [Related]
14. Inhibiting ROS-STAT3-dependent autophagy enhanced capsaicin-induced apoptosis in human hepatocellular carcinoma cells.
Chen X; Tan M; Xie Z; Feng B; Zhao Z; Yang K; Hu C; Liao N; Wang T; Chen D; Xie F; Tang C
Free Radic Res; 2016 Jul; 50(7):744-55. PubMed ID: 27043357
[TBL] [Abstract][Full Text] [Related]
15. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
Zuo M; Li C; Lin J; Javle M
Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212
[TBL] [Abstract][Full Text] [Related]
16. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling.
Zou M; Lu N; Hu C; Liu W; Sun Y; Wang X; You Q; Gu C; Xi T; Guo Q
Cell Signal; 2012 Aug; 24(8):1722-32. PubMed ID: 22560876
[TBL] [Abstract][Full Text] [Related]
17. Flavonoids as potential anti-hepatocellular carcinoma agents: recent approaches using HepG2 cell line.
Xia JF; Gao JJ; Inagaki Y; Kokudo N; Nakata M; Tang W
Drug Discov Ther; 2013 Feb; 7(1):1-8. PubMed ID: 23524937
[TBL] [Abstract][Full Text] [Related]
18. Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.
Zhang C; Li H; Jiang W; Zhang X; Li G
Oncotarget; 2016 Dec; 7(50):83755-83766. PubMed ID: 27835879
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative and Cytotoxic Activity of Xanthohumol and Its Non-Estrogenic Derivatives in Colon and Hepatocellular Carcinoma Cell Lines.
Logan IE; Miranda CL; Lowry MB; Maier CS; Stevens JF; Gombart AF
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857300
[TBL] [Abstract][Full Text] [Related]
20. Myricetin Suppresses the Propagation of Hepatocellular Carcinoma via Down-Regulating Expression of YAP.
Li M; Chen J; Yu X; Xu S; Li D; Zheng Q; Yin Y
Cells; 2019 Apr; 8(4):. PubMed ID: 30999669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
